Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by Golddetectoron Jan 17, 2022 11:10pm

242 Views

Post# 34327058

Today’s volume 2 millions

It is an oversold case imo. The volume started very low in the first 3 hrs in the morning. Once ppl ensured no more sellers at 12c then start clearing penny flippers up to 13.5c. 13.5c still very cheap so might see few of these clear ups and next few days. I hope to see more slow and steady clearing but not many ppl want to sell at all time lows. We are also getting closer to reduvo approval but I'm really looking forward for QIXLEEF phase II Reborn interim that will be the big one. Gl longs

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments